wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27276774-CB25B6E3-A3F2-4795-B8DD-5559D419C645
Q27276774-CB25B6E3-A3F2-4795-B8DD-5559D419C645
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27276774-CB25B6E3-A3F2-4795-B8DD-5559D419C645
Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
P2860
Q27276774-CB25B6E3-A3F2-4795-B8DD-5559D419C645
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27276774-CB25B6E3-A3F2-4795-B8DD-5559D419C645
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b280a4b090935d00564d27b5ce4b4836b6d1c78e
P2860
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma